We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
326
Goldman Sachs
GS
$309B
$896K 0.11%
1,809
-360
-17% -$176K
PYCR
327
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$895K 0.11%
63,051
+37,093
+143% +$493K
ALKT icon
328
Alkami Technology
ALKT
$1.9B
$892K 0.11%
28,297
-947
-3% -$29.9K
DCH
329
Dauch Corp
DCH
$1.32B
$892K 0.11%
144,307
-46,001
-24% -$300K
NEM icon
330
Newmont
NEM
$98.5B
$891K 0.11%
16,666
+5,501
+49% +$273K
ONON icon
331
On Holding
ONON
$12.4B
$890K 0.11%
+17,755
New +$762K
STE icon
332
Steris
STE
$21.3B
$890K 0.11%
+3,671
New +$858K
CLS icon
333
Celestica
CLS
$36.6B
$889K 0.11%
17,397
+13,693
+370% +$708K
PEB icon
334
Pebblebrook Hotel Trust
PEB
$2.19B
$888K 0.11%
+67,142
New +$882K
BAP icon
335
Credicorp
BAP
$31.1B
$887K 0.11%
4,901
-1,255
-20% -$214K
RLJ icon
336
RLJ Lodging Trust
RLJ
$1.9B
$887K 0.11%
96,572
+52,447
+119% +$491K
BF.B icon
337
Brown-Forman Class B
BF.B
$12.6B
$884K 0.11%
+17,960
New +$808K
KWR icon
338
Quaker Houghton
KWR
$2.63B
$884K 0.11%
5,244
-1,660
-24% -$281K
BMO icon
339
Bank of Montreal
BMO
$125B
$882K 0.11%
9,774
+7,112
+267% +$607K
HUBG icon
340
HUB Group
HUBG
$2.93B
$880K 0.11%
19,363
-6,016
-24% -$267K
SYK icon
341
Stryker
SYK
$129B
$880K 0.11%
+2,436
New +$841K
GH icon
342
Guardant Health
GH
$19.3B
$880K 0.11%
+38,361
New +$1.09M
B
343
DELISTED
Barnes Group Inc.
B
$873K 0.1%
+21,615
New +$851K
ADP icon
344
Automatic Data Processing
ADP
$102B
$872K 0.1%
+3,150
New +$824K
FR icon
345
First Industrial Realty Trust
FR
$8.81B
$868K 0.1%
15,505
+10,982
+243% +$592K
HP icon
346
Helmerich & Payne
HP
$3.36B
$868K 0.1%
28,523
-1,096
-4% -$37.9K
G icon
347
Genpact
G
$5.45B
$867K 0.1%
22,119
+11,058
+100% +$400K
INCY icon
348
Incyte
INCY
$23.7B
$867K 0.1%
+13,119
New +$837K
AIN icon
349
Albany International
AIN
$2.16B
$866K 0.1%
9,751
+350
+4% +$30.8K
NOMD icon
350
Nomad Foods
NOMD
$1.67B
$862K 0.1%
45,211
-43,661
-49% -$804K
12 13
14
15 16

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.